Tolerability and effectiveness of preservative-free dorzolamide–timolol (preservative-free COSOPT(®)) in patients with open-angle glaucoma or ocular hypertension

Documenti analoghi

• Patient perspectives when switching from Cosopt(®) (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy
  di: Auger, Graham Anthony, et al.
  Pubblicazione: (2012)
• A patient preference comparison of Azarga(™) (brinzolamide/timolol fixed combination) vs Cosopt(®) (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension
  di: Mundorf, Thomas K, et al.
  Pubblicazione: (2008)
• Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
  di: Teus, Miguel A, et al.
  Pubblicazione: (2009)
• 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
  di: Konstas, Anastasios-Georgios, et al.
  Pubblicazione: (2016)
• Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
  di: Konstas, Anastasios-Georgios, et al.
  Pubblicazione: (2020)